Sign In
Buy BTAFF
British American Tobacco p.l.c Earnings Calls
| Release date | Feb 12, 2026 |
| EPS estimate | $2.52 |
| EPS actual | $2.52 |
| Revenue estimate | 17.947B |
| Revenue actual | 18.213B |
| Revenue Surprise | 1.48% |
| Release date | Jul 31, 2025 |
| EPS estimate | $2.25 |
| EPS actual | $2.79 |
| EPS Surprise | 24.00% |
| Revenue estimate | 16.482B |
| Revenue actual | 16.447B |
| Revenue Surprise | -0.213% |
| Release date | Apr 24, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 13, 2025 |
| EPS estimate | $2.42 |
| EPS actual | -$0.80 |
| EPS Surprise | -133.09% |
| Revenue estimate | 17.427B |
| Revenue actual | 16.924B |
| Revenue Surprise | -2.88% |
Last 4 Quarters for British American Tobacco p.l.c
Below you can see how BTAFF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 13, 2025 |
| Price on release | $40.33 |
| EPS estimate | $2.42 |
| EPS actual | -$0.80 |
| EPS surprise | -133.09% |
| Date | Price |
|---|---|
| Feb 07, 2025 | $41.12 |
| Feb 10, 2025 | $41.63 |
| Feb 11, 2025 | $43.57 |
| Feb 12, 2025 | $41.74 |
| Feb 13, 2025 | $40.33 |
| Feb 14, 2025 | $38.75 |
| Feb 18, 2025 | $38.66 |
| Feb 19, 2025 | $37.46 |
| Feb 20, 2025 | $37.10 |
| 4 days before | -1.92% |
| 4 days after | -8.01% |
| On release day | 0.389% |
| Change in period | -9.78% |
| Release date | Apr 24, 2025 |
| Price on release | $44.43 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 17, 2025 | $43.31 |
| Apr 21, 2025 | $41.45 |
| Apr 22, 2025 | $42.23 |
| Apr 23, 2025 | $42.00 |
| Apr 24, 2025 | $44.43 |
| Apr 25, 2025 | $43.98 |
| Apr 28, 2025 | $41.04 |
| Apr 29, 2025 | $41.95 |
| Apr 30, 2025 | $42.79 |
| 4 days before | 2.59% |
| 4 days after | -3.69% |
| On release day | 0% |
| Change in period | -1.20% |
| Release date | Jul 31, 2025 |
| Price on release | $52.72 |
| EPS estimate | $2.25 |
| EPS actual | $2.79 |
| EPS surprise | 24.00% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $54.53 |
| Jul 28, 2025 | $51.95 |
| Jul 29, 2025 | $53.28 |
| Jul 30, 2025 | $52.20 |
| Jul 31, 2025 | $52.72 |
| Aug 01, 2025 | $55.05 |
| Aug 04, 2025 | $57.90 |
| Aug 05, 2025 | $58.30 |
| Aug 06, 2025 | $58.86 |
| 4 days before | -3.32% |
| 4 days after | 11.64% |
| On release day | 4.42% |
| Change in period | 7.94% |
| Release date | Feb 12, 2026 |
| Price on release | $61.31 |
| EPS estimate | $2.52 |
| EPS actual | $2.52 |
| Date | Price |
|---|---|
| Feb 06, 2026 | $64.29 |
| Feb 09, 2026 | $60.66 |
| Feb 10, 2026 | $60.66 |
| Feb 11, 2026 | $60.66 |
| Feb 12, 2026 | $61.31 |
| Feb 13, 2026 | $61.31 |
| Feb 17, 2026 | $60.59 |
| Feb 18, 2026 | $61.12 |
| Feb 19, 2026 | $59.28 |
| 4 days before | -4.63% |
| 4 days after | -3.32% |
| On release day | 0% |
| Change in period | -7.80% |
British American Tobacco p.l.c Earnings Call Transcript Summary of Q4 2025
Key points for investors: BAT delivered full-year 2025 results at the top end of guidance, driven by a strong U.S. combustible performance and robust growth in new categories—especially modern oral (Velo). The company added 4.7 million smokeless consumers (total 34.1m), achieved double‑digit new category revenue growth in H2, and improved new category contribution (GBP 442m). Velo Plus rapidly gained share in the U.S., reached positive category contribution within 12 months, and helped Velo secure global volume share leadership in Modern Oral across top markets. Group adjusted profit rose ~3.4% and adjusted diluted EPS increased ~3.4%. BAT generated strong cash flow, increased the 2026 share buyback to GBP 1.3bn, raised the dividend, and continues to deleverage toward its 2.0–2.5x net debt/EBITDA target. Management reiterated the midterm algorithm (3–5% revenue growth; 4–6% adjusted profit from operations growth; 5–8% adjusted diluted EPS growth), while flagging regional headwinds (Bangladesh, Australia, parts of APMEA) and ongoing illicit competition in vapor that is constraining near-term vapor growth. The company expects further productivity savings (targeting an additional GBP 2bn by 2030, with Fit to Win delivering ~GBP 600m incremental annualized savings by 2028) and will invest behind premium innovations (glo Hilo, Velo Shift, Vuse Ultra) to drive longer‑term value.
